menu
    • menu

    Company profile for Genetix Biotherapeutics

    NEW Drugs in Dev: 10
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Genetix Biotherapeutics is a privately held, commercial-stage biotechnology company dedicated to delivering curative genetic therapies for severe rare diseases. Formerly bluebird bio, the company has three FDA-approved, first-in-class gene therapies for sickle cell disease, β-thalassemia and cerebral adrenoleukodystrophy. These one-time treatments address the underlying cause of disease and provide durable benefit. Building o...
    Genetix Biotherapeutics is a privately held, commercial-stage biotechnology company dedicated to delivering curative genetic therapies for severe rare diseases. Formerly bluebird bio, the company has three FDA-approved, first-in-class gene therapies for sickle cell disease, β-thalassemia and cerebral adrenoleukodystrophy. These one-time treatments address the underlying cause of disease and provide durable benefit. Building on decades of scientific innovation and clinical experience, Genetix is focused on expanding patient access and strengthening the treatment experience for patients, families and healthcare providers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Genetix BiotherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    60 Binney St. Cambridge, MA 02142
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.genetixbiotx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Bio-Europe Spring

    Bio-Europe Spring

    Not Confirmed

    envelop Contact Supplier

    Bio-Europe Spring

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Genetix Unveils 2025 Commercial Results, 2026 Strategic Plan
    Genetix Unveils 2025 Commercial Results, 2026 Strategic Plan

    02 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-02/genetix-announces-2025-commercial-performance-results-and-outlines-2026-strategic-priorities

    PHARMIWEB
    02 Mar 2026
    Share Share
    Minaris And Genetix Bio Expand Partnership For LYFGENIA
    Minaris And Genetix Bio Expand Partnership For LYFGENIA

    12 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/minaris-and-genetix-biotherapeutics-expand-manufacturing-partnership-to-support-commercial-supply-for-lyfgenia-lovotibeglogene-autotemcel-302658158.html

    PR NEWSWIRE
    12 Jan 2026
    Share Share
    Bluebird Rebrands Post Private Buyout, as Gene Therapy Biotech
    Bluebird Rebrands Post Private Buyout, as Gene Therapy Biotech

    19 Sep 2025

    // BIOSPACE

    https://www.biospace.com/business/bye-bye-bluebird-gene-therapy-biotech-emerges-from-private-buyout-with-rebrand

    BIOSPACE
    19 Sep 2025
    Share Share
    Bluebird Bio Rebrands as Genetix Bio, Returns to Roots
    Bluebird Bio Rebrands as Genetix Bio, Returns to Roots

    18 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-18/bluebird-bio-rebrands-as-genetix-biotherapeutics-returning-to-its-foundational-roots

    PHARMAWEB
    18 Sep 2025
    Share Share
    FDA Restricts Bluebird Bio Therapy Skysona After Cancer Reports
    FDA Restricts Bluebird Bio Therapy Skysona After Cancer Reports

    12 Aug 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/fda-restricts-bluebird-bio-gene-therapy-skysona-after-blood-cancer-reports

    FIERCE PHARMA
    12 Aug 2025
    Share Share
    bluebird bio Bolsters Management Team with Appointments
    bluebird bio Bolsters Management Team with Appointments

    01 Jul 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/bluebird-bio-bolsters-management-team-with-appointments/

    CONTRACTPHARMA
    01 Jul 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search